False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma
- 25 July 2000
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 35 (2) , 153-155
- https://doi.org/10.1002/1096-911x(200008)35:2<153::aid-mpo18>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical Impact and Prognostic Value of Metaiodobenzylguanidine Imaging in Children With Metastatic NeuroblastomaJournal of Pediatric Hematology/Oncology, 1999
- Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.The British Journal of Radiology, 1997
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the pediatric oncology groupCancer, 1992
- Radio-iodobenzylguanidine scintigraphy of neuroblastoma: Conflicting results, when compared with standard investigationsMedical and Pediatric Oncology, 1989
- I‐131 metaiodobenzylguanidine: Diagnostic use in neuroblastoma patients in relapseMedical and Pediatric Oncology, 1988
- Three Years of Experience With Random Urinary Homovanillic and Vanillylmandelic Acid Levels in the Diagnosis of NeuroblastomaPediatrics, 1987
- 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomasSeminars in Nuclear Medicine, 1985
- Tyrosine hydroxylase and choline acetyltransferase activity in human neuroblastoma correlations with clinical featuresCancer, 1983